Navigation Links
Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment

tigue, upper respiratory tract infection, nasopharyngitis, increased ALT, arthralgia, and headache. -- There were no deaths or treatment discontinuations due to adverse events. -- Nine percent (n=9/99) of patients experienced a serious adverse event. Serious adverse events included ALT elevation or hepatitis exacerbation (4), bilirubin elevation (1), inguinal hernia (1), sialoadenitis (1), thrombocytopenic purpura (1), groin pain (1), macular edema (1), urinary incontinence (1) and cholelithiasis (1). Two of these events, hepatitis exacerbation (1) and thrombocytopenia (1), were considered possibly related to treatment by the investigator. -- Five percent (n=5/99) of patients experienced an ALT flare on treatment (ALT > 2 times baseline and >10 times the upper level of normal) About BARACLUDE(R) (entecavir)

Discovered at Bristol-Myers Squibb, BARACLUDE(R) (entecavir) is a nucleoside analogue indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication with either evidence of persistent elevations in serum aminotransferases (ALT or AST) or histologically active disease. BARACLUDE has been approved in more than 60 countries and regions around the world.

Important Information About BARACLUDE(R) (entecavir) 0.5mg/1mg Tablets

BARACLUDE(R) (entecavir) is a prescription medicine used for chronic infection with hepatitis B virus (HBV) in adults where the virus is multiplying and damaging the liver. BARACLUDE does not cure HBV or stop the spread of HBV to others.

People should not take BARACLUDE if they are allergic to it or any of its ingredients. BARACLUDE has not been studied in children and is not recommended for anyone less than 16 years of age.

People taking BARACLUDE(R) (entecavir) should tell their healthcare provider right away if they feel very weak or tired, have unusual muscle pain, have trouble breathing, have stomach pain with nausea and vomiting, feel cold - especi
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Baraclude (Entecavir) Treatment Demonstrated Greater Viral Load Reduction Compared to Adefovir at 48 Weeks in Study of Antiviral-Naive Chronic Hepatitis B E-Antigen Positive Patients
2. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
3. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
4. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
5. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
6. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
7. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
8. Lexicon Develops Antibodies That Lower Triglycerides and Cholesterol as Potential New Therapy for Heart Disease
9. Studies of Drug Resistance May Lead to Individual Therapy for Rare Cancers
10. Velcade (bortezomib) for Injection Based Induction Therapy Delivered High Post-Transplant Complete Remission Rate, a Critical Marker for Increased Overall Survival
11. A 4-Week Therapy with Transition Therapeutics E1-I.N.T. Leads to Sustained Reductions in Blood Glucose Levels for 6 Months Post-treatment in Type 2 Diabetes Patients
Post Your Comments:
(Date:7/23/2014)... , July 23, 2014 Research ... "Disposable Medical Gloves (Exam and Surgical) Markets Worldwide ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of ... market for Disposable Medical (Exam and Surgical) Gloves. The ... market for these products. Topics covered include ...
(Date:7/23/2014)... 23, 2014  The management team at Columbia ... hold a conference call on July 31, 2014, ... ended June 30, 2014.  The call details are ... 8:30 am EDTDial-in numbers: , Toll free: (877) ... (live & archive): , www.columbialabs.com , under ...
(Date:7/23/2014)...  Silk Road Medical, Inc., a developer of ... and extra-cranial cerebrovascular disease, announced today the appointment ... position of Chief Technology Officer.  In this new ... Development efforts across its family of transcarotid access ... joining Silk Road Medical, Michael was the Vice ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... announces that a new market research report is available ... of Xylose in China http://www.reportlinker.com/p0260046/Production-and-Market-of-Xylose-in-China.html ... global financial crisis in Q4 2008, Chinese xylose production ... or even stopped production due to declining profit and ...
... improve vision-related quality of life in children compared with ... according to data drawn from a three-year multi-site study ... the self-perception of nearsighted children ages eight to 11 ... may be more considerable after 10 years of age. ...
Cached Medicine Technology:Reportlinker Adds Production and Market of Xylose in China 2Reportlinker Adds Production and Market of Xylose in China 3Children Report Better Vision-Related Quality of Life with Contact Lenses vs. Glasses 2
(Date:7/23/2014)... NJ (PRWEB) July 23, 2014 Celebrating ... for New Jersey today announced the awarding of $1,070,000 ... a special award in recognition of the Foundation’s 1,000th ... proud to continue our tradition of supporting community-based organizations ... the quality of life in the Garden State,” said ...
(Date:7/23/2014)... (HealthDay News) -- Painful or itchy skin lesions could ... "Patients sometimes have multiple lesions that are suspicious ... raise high concerns for non-melanoma skin cancers," study author ... School of Medicine, said in a Temple University Health ... records of 268 patients who were confirmed to have ...
(Date:7/23/2014)... University in Shaanxi province, and the University of California, ... the groundwork for establishing the Sino-U.S. Joint Research Center ... was held in the city of Yingchuan, China, during ... of Agriculture and China,s Ministry of Science and Technology. ... Davis and for our World Food Center and serves ...
(Date:7/23/2014)... Washington, DC (PRWEB) July 23, 2014 ... presenters for ATA 2015, ATA’s twentieth annual meeting ... mHealth. The meeting, expected to attract over 5,000 ... vendors, will take place May 3-5, 2015, in ... world’s most renowned healthcare technology professionals from researchers, ...
(Date:7/23/2014)... 2014 Bodybuilding.com, the Internet’s most-visited bodybuilding ... nutritional supplements, has officially opened the polls for their ... the fastest growing sports nutrition company, is up for ... the Year, Best Tasting Protein of the Year- Whey-HD™, ... the year - Whey-HD™, Pre-workout Supplement of the Year ...
Breaking Medicine News(10 mins):Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 2Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 3Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 4Health News:The Horizon Foundation for New Jersey Awards More than $1 million in Grants to 20 Non-profit Organizations 5Health News:Painful, Itchy Patches Could Be Sign of Skin Cancer 2Health News:Global food safety research agreement signed by China and UC Davis 2Health News:Global food safety research agreement signed by China and UC Davis 3Health News:ATA Seeks Speakers to Present at the World’s Largest Telemedicine, mHealth and Telehealth Conference 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 2Health News:Vote Now; BPI SPORTS is Nominated for Eight 2014 Bodybuilding.com Supplement Awards 3
... 18 InfoLogix, I nc. ... provider of enterprise mobility solutions for the healthcare and commercial ... Mobility Validation for the InfoLogix Mobile Devi ... platform for mobile asset tracking and bar code solutions. This ...
... , Project Access San Diego, in ... for 46 Uninsured San Diego County Patients , , ... Diego County patients will receive donated outpatient surgeries and procedures ... Project Access San Diego (PASD), a program of the San ...
... sign of progress against drug-resistant bacteria, , TUESDAY, ... treat respiratory tract infections has dropped significantly in ... That,s mainly the result of fewer young children ... researchers. But despite a decline overall, prescriptions for ...
... , ... a new choice in personal care ointments. , ... Vancouver, BC (Vocus) August 18, 2009 -- Customers across ... Shoppers Drug Mart/Pharmaprix will begin selling Théra Wise HmR Natural Hemorrhoidal Ointment . ...
... , , , DOYLESTOWN, Pa., Aug. 18 ... QGLY ), www.qu i ... of Directors has approved updating and amending its By-laws and Rights Agreement. , ... to reflect accepted best practices, including updates with respect to Nevada corporate law ...
... Hospitals, Physicians Work Together to Cut Costs, Improve Quality ... Twelve New Jersey hospitals and their participating physicians are taking part ... evaluate gainsharing as an innovative new incentive method that aims to ... "Rising healthcare costs are a growing burden for all ...
Cached Medicine News:Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 2Health News:InfoLogix Achieves Motorola Enterprise Mobility Validation 3Health News:Uninsured Patients to Receive Free Surgeries, Procedures 2Health News:Uninsured Patients to Receive Free Surgeries, Procedures 3Health News:Uninsured Patients to Receive Free Surgeries, Procedures 4Health News:Antibiotics Being Prescribed Less for Respiratory Infections 2Health News:Antibiotics Being Prescribed Less for Respiratory Infections 3Health News:Thra Wise All-Natural Ointment Now Available at Shoppers Drug Mart 2Health News:Thra Wise All-Natural Ointment Now Available at Shoppers Drug Mart 3Health News:The Quigley Corporation Updates and Amends By-Laws and Rights Agreement 2Health News:The Quigley Corporation Updates and Amends By-Laws and Rights Agreement 3Health News:Update: Medicare Picks N.J. to Test Innovative Incentive System 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: